Stay updated with breaking news from Nasdaq Pmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Psychemedics Co. (NASDAQ:PMD – Get Rating) major shareholder Peter Kamin bought 27,485 shares of the business’s stock in a transaction on Tuesday, April 19th. The shares were acquired at an average cost of $6.52 per share, with a total value of $179,202.20. Following the purchase, the insider now owns 216,778 shares of the company’s stock, […]
Psychemedics Co. (NASDAQ:PMD – Get Rating) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 10,200 shares, a drop of 29.2% from the March 15th total of 14,400 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average trading […]
Psychemedics Co. (NASDAQ:PMD – Get Rating) major shareholder Peter Kamin acquired 3,000 shares of the company’s stock in a transaction on Thursday, April 7th. The stock was bought at an average cost of $6.68 per share, with a total value of $20,040.00. Following the completion of the acquisition, the insider now directly owns 205,931 shares […]
Psychemedics Co. (NASDAQ:PMD – Get Rating) major shareholder Peter Kamin purchased 3,000 shares of the business’s stock in a transaction on Thursday, April 7th. The shares were bought at an average cost of $6.68 per share, for a total transaction of $20,040.00. Following the purchase, the insider now owns 205,931 shares of the company’s stock, […]
Psychemedics Co. (NASDAQ:PMD – Get Rating) major shareholder Peter Kamin bought 4,000 shares of Psychemedics stock in a transaction on Wednesday, March 16th. The stock was purchased at an average price of $6.51 per share, with a total value of $26,040.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which […]